These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 35845934)

  • 1. Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and
    Darabi F; Saidijam M; Nouri F; Mahjub R; Soleimani M
    Biomed Res Int; 2022; 2022():6253978. PubMed ID: 35845934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer.
    Chaudhuri A; Naveen Kumar D; Kumar D; Kumar Agrawal A
    Eur J Pharm Biopharm; 2024 Aug; 201():114386. PubMed ID: 38950717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
    Zheng G; Zheng M; Yang B; Fu H; Li Y
    Biomed Pharmacother; 2019 Aug; 116():109006. PubMed ID: 31152925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.
    Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H
    Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer.
    Pindiprolu SKSS; Krishnamurthy PT; Dev C; Chintamaneni PK
    Chem Phys Lipids; 2021 Mar; 235():105033. PubMed ID: 33385372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulated Oxovanadium(IV) and Dioxovanadium(V) Complexes into Solid Lipid Nanoparticles Increase Cytotoxicity Against MDA-MB-231 Cell Line.
    Kostrzewa T; Nowak I; Feliczak-Guzik A; Drzeżdżon J; Jacewicz D; Górska-Ponikowska M; Kuban-Jankowska A
    Int J Nanomedicine; 2023; 18():2507-2523. PubMed ID: 37197025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, Statistical Optimization and Characterization of Propolis-Loaded Solid Lipid Nanoparticles Using Box-Behnken Design.
    Taherzadeh S; Naeimifar A; Mehrabani Yeganeh E; Esmaili Z; Mahjoub R; Akbari Javar H
    Adv Pharm Bull; 2021 Feb; 11(2):301-310. PubMed ID: 33880352
    [No Abstract]   [Full Text] [Related]  

  • 9. Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells.
    Pindiprolu SKSS; Chintamaneni PK; Krishnamurthy PT; Ratna Sree Ganapathineedi K
    Drug Dev Ind Pharm; 2019 Feb; 45(2):304-313. PubMed ID: 30348020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, Statistical Optimization, and Characterization of Resveratrol-Containing Solid Lipid Nanoparticles (SLNs) and Determination of the Efficacy in Reducing Neurodegenerative Symptoms Related to Alzheimer's Disease: In Vitro and In Vivo Study.
    Khishvand MA; Yeganeh EM; Zarei M; Soleimani M; Mohammadi M; Mahjub R
    Biomed Res Int; 2024; 2024():7877265. PubMed ID: 39376256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
    Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
    J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery.
    Sohaib M; Shah SU; Shah KU; Shah KU; Khan NR; Irfan MM; Niazi ZR; Alqahtani AA; Alasiri A; Walbi IA; Mahmood S
    Biomed Res Int; 2022; 2022():7792180. PubMed ID: 35971450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid Lipid Nanoformulation of Berberine Attenuates Doxorubicin Triggered
    Rawal S; Gupta P; Bhatnagar P; Yadav HN; Dinda AK
    Comb Chem High Throughput Screen; 2022; 25(10):1695-1706. PubMed ID: 35718970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer.
    Kutlehria S; Behl G; Patel K; Doddapaneni R; Vhora I; Chowdhury N; Bagde A; Singh M
    AAPS PharmSciTech; 2018 Feb; 19(2):792-802. PubMed ID: 29019073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Perphenazine-Loaded Solid Lipid Nanoparticles: Statistical Optimization and Cytotoxicity Studies.
    Farsani PA; Mahjub R; Mohammadi M; Oliaei SS; Mahboobian MM
    Biomed Res Int; 2021; 2021():6619195. PubMed ID: 33997026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
    Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
    Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
    Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
    Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin.
    Jain A; Kesharwani P; Garg NK; Jain A; Jain SA; Jain AK; Nirbhavane P; Ghanghoria R; Tyagi RK; Katare OP
    Colloids Surf B Biointerfaces; 2015 Oct; 134():47-58. PubMed ID: 26142628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules.
    Alhamhoom Y; Ravi G; Osmani RAM; Hani U; Prakash GM
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.